Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 28, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
04:41

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue

Published on: July 28, 2023

Current Approach to Keloid Management.

Mislav Rončević1, Zrinka Bukvić Mokos, Romana Čeović

  • 1Mislav Rončević, University of Zagreb School of Medicine, Šalata 3, Zagreb, Croatia; roncevic.mislav@gmail.com.

Acta Dermatovenerologica Croatica : ADC
|June 26, 2026
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Unusual Case of Granulomatosis with Polyangiitis Complicated with Hormographilella aspergillata Skin Infection.

Acta dermatovenerologica Croatica : ADC·2026
Same author

Calciphylaxis as a Rare Complication Associated with Pemigatinib Treatment-A Case Report.

Current oncology (Toronto, Ont.)·2026
Same author

International development of Investigator Global Assessment scores for pemphigus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Cutaneous Squamous Cell Carcinoma Developing in Necrobiosis Lipoidica - A Case Report with Literature Review.

Dermatology practical & conceptual·2026
Same author

Update of the EuroGuiDerm evidence-based guideline for the treatment of acne-Short version.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025

Keloid treatments face challenges with high recurrence rates and lack of standard protocols. Further high-quality research is crucial for improved keloid management strategies.

Area of Science:

  • Dermatology
  • Wound Healing Research
  • Fibroproliferative Disorders

Background:

  • Keloids are benign skin tumors arising from abnormal wound healing.
  • Characterized by fibroblast hyperactivity, excess collagen, and apoptosis resistance.
  • Lesions cause physical and psychological distress, with challenging management and high recurrence.

Purpose of the Study:

  • To review current keloid treatment efficacy and limitations.
  • To discuss emerging therapeutic approaches for keloid management.
  • To highlight the need for advanced keloid-specific research.

Main Methods:

  • Comprehensive literature review of keloid treatments.
  • Analysis of existing modalities: silicone sheets, injections, cryotherapy, radiotherapy, laser, surgery.

Related Experiment Videos

Last Updated: Jun 28, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
04:41

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue

Published on: July 28, 2023

  • Exploration of novel therapies: botulinum toxin, antihypertensives, PRP.

    • Main Results:

    • Current keloid treatments show variable efficacy and significant limitations.
    • High recurrence rates persist across many therapeutic options.
    • Emerging therapies offer potential but require further validation.

    Conclusions:

    • Keloid management remains complex due to treatment variability and recurrence.
    • Standardized protocols and high-quality, keloid-exclusive studies are essential.
    • Advancing therapeutic strategies requires rigorous scientific investigation.